US equities
|
SPCX
$157.93
▲+6.86%
MU
$913.96
▲+2.00%
NVDA
$220.74
▲+1.97%
TSLA
$385.36
▲+3.12%
META
$705.13
▲+1.57%
SNDK
$1,379.54
▲+1.04%
AMD
$553.56
▲+3.52%
AAPL
$343.64
▲+1.22%
SPCX
$157.93
▲+6.86%
MU
$913.96
▲+2.00%
NVDA
$220.74
▲+1.97%
TSLA
$385.36
▲+3.12%
META
$705.13
▲+1.57%
SNDK
$1,379.54
▲+1.04%
AMD
$553.56
▲+3.52%
AAPL
$343.64
▲+1.22%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Thomas Stephan
Recent news which mentions Thomas Stephan
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Tickers
ALC
JNJ
RXST
Tags
Stifel
pharmaceutical stocks
Crohn's Disease
From
Benzinga